Factory Supply Dipyridamole Powder Pharmaceutical Dipyridamole Raw Material Dipyridamole

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung-Dipyridamole
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Dipyridamole
• Name: Dipyridamole Powder
• Appearance: Yellow Powder
• Color: Yellow Color
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical
• Specific: COA
• Test Method: HPLC UV
• Shelf Life: 2 Years
• CAS No.: 58-32-2
• Mf: C24h40n8o4
• MW: 504.6256
• Melting Point: 165-166ºC
• Density: 1.352
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 8000kg/Month

Product Description

Factory Supply Dipyridamole Powder Pharmaceutical Dipyridamole Raw Material Dipyridamole

Product Description

Product Details

Product name	Dipyridamole
Cas number	58-32-2
Apperance	Yellow Powder
MF	C24H40N8O4
MW	504.6256
Melting point	165-166ºC
Density	1.352

Dipyridamole is a PDE (phosphodiesterase) inhibitor with antioxidant properties. This compound has been shown to suppress.
Research indicates that Dipyridamole is a non-specific nucleoside transport inhibitor with the ability to increase the effects of adenosine in sinoatrial and atrioventricular nodes. Dipyridamole is an inhibitor of ENT1 and ENT2.

Application&Function

Dipyridamole, a coronary artery dilator and antithrombotic drug, is used mainly for ischemic heart disease and stroke, but to a lesser extent for other conditions.Its side effects may include headache, dizziness, nausea, vomiting, diarrhea and other adverse reactions. Combined with heparin, it may cause bleeding tendency, occasional rash, and coronary artery blood theft.Early years used to be the treatment of coronary heart disease drugs, now less used as an anti-myocardial ischemia.Its anti-platelet aggregation effect can be used in cardiac surgery or valve replacement, which can reduce the formation of thromboembolism.

Specification